Phreesia Inc (PHR)
21.94
-1.20
(-5.19%)
USD |
NYSE |
Apr 24, 16:00
21.94
0.00 (0.00%)
After-Hours: 20:00
Phreesia Cash from Investing (TTM): -39.67M for Jan. 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
January 31, 2024 | -39.67M |
October 31, 2023 | -38.11M |
July 31, 2023 | -29.12M |
April 30, 2023 | -25.26M |
January 31, 2023 | -26.20M |
October 31, 2022 | -60.27M |
July 31, 2022 | -68.05M |
April 30, 2022 | -65.35M |
January 31, 2022 | -65.23M |
October 31, 2021 | -38.54M |
July 31, 2021 | -27.74M |
Date | Value |
---|---|
April 30, 2021 | -28.91M |
January 31, 2021 | -25.08M |
October 31, 2020 | -14.27M |
July 31, 2020 | -14.08M |
April 30, 2020 | -12.67M |
January 31, 2020 | -12.32M |
October 31, 2019 | -13.04M |
July 31, 2019 | -11.80M |
April 30, 2019 | -11.82M |
January 31, 2019 | -11.02M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-68.05M
Minimum
Jul 2022
-11.80M
Maximum
Jul 2019
-31.38M
Average
-26.97M
Median
Cash from Investing (TTM) Benchmarks
Teladoc Health Inc | -156.35M |
American Shared Hospital Services | -6.273M |
Novo Integrated Sciences Inc | -- |
Astrana Health Inc | -65.52M |
Cryo-Cell International Inc | -7.284M |